These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 27329502)
1. A human gut ecosystem protects against C. difficile disease by targeting TcdA. Martz SL; Guzman-Rodriguez M; He SM; Noordhof C; Hurlbut DJ; Gloor GB; Carlucci C; Weese S; Allen-Vercoe E; Sun J; Claud EC; Petrof EO J Gastroenterol; 2017 Apr; 52(4):452-465. PubMed ID: 27329502 [TBL] [Abstract][Full Text] [Related]
2. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model. Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596 [TBL] [Abstract][Full Text] [Related]
3. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure. Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481 [TBL] [Abstract][Full Text] [Related]
4. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928 [TBL] [Abstract][Full Text] [Related]
5. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins. Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988 [TBL] [Abstract][Full Text] [Related]
6. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early Ok MT; Liu J; Bliton RJ; Hinesley CM; San Pedro EET; Breau KA; Gomez-Martinez I; Burclaff J; Magness ST Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G262-G280. PubMed ID: 36749911 [No Abstract] [Full Text] [Related]
7. The Importance of Therapeutically Targeting the Binary Toxin from Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767 [TBL] [Abstract][Full Text] [Related]
8. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum. Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583 [TBL] [Abstract][Full Text] [Related]
9. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection. Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479 [TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling. Chen X; Yang X; de Anda J; Huang J; Li D; Xu H; Shields KS; Džunková M; Hansen J; Patel IJ; Yee EU; Golenbock DT; Grant MA; Wong GCL; Kelly CP Gastroenterology; 2020 Dec; 159(6):2181-2192.e1. PubMed ID: 32841647 [TBL] [Abstract][Full Text] [Related]
12. tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile. Couturier B; Schlaberg R; Konzak C; Nicholes J; Law C; She RC J Clin Lab Anal; 2013 May; 27(3):171-6. PubMed ID: 23686774 [TBL] [Abstract][Full Text] [Related]
14. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection. Shin BM; Kuak EY; Lee EJ; Songer JG J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481 [TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression. Coffing H; Priyamvada S; Anbazhagan AN; Salibay C; Engevik M; Versalovic J; Yacyshyn MB; Yacyshyn B; Tyagi S; Saksena S; Gill RK; Alrefai WA; Dudeja PK Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G43-G52. PubMed ID: 29597352 [TBL] [Abstract][Full Text] [Related]
16. Mouse relapse model of Clostridium difficile infection. Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341 [TBL] [Abstract][Full Text] [Related]
17. Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy. Koya SK; Yurgelevic S; Brusatori M; Huang C; Diebel LN; Auner GW J Surg Res; 2019 Dec; 244():111-116. PubMed ID: 31279995 [TBL] [Abstract][Full Text] [Related]
18. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245 [TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Alginate and Chitosan Oligosaccharides against Mavrogeni ME; Asadpoor M; Judernatz JH; van Ark I; Wösten MMSM; Strijbis K; Pieters RJ; Folkerts G; Braber S Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888617 [No Abstract] [Full Text] [Related]
20. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran. Doosti A; Mokhtari-Farsani A Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]